Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-038052 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
350,672
Total Value
$226,300.30
P&L
+inf% (+$5,747,406.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Feb 2, 2026 | Grant/Award | 47,460 | $0.00 | $0.00 | 205,670 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Feb 3, 2026 | Sale | 18,251 | $12.26 | $223,707.98 | 187,419 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Feb 3, 2026 | Sale | 201 | $12.90 | $2,592.32 | 187,218 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 284,760 | $0.00 | $0.00 | 284,760 | Direct | โ | View Details |